AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

LYNESTRENOL

8 registrations across 6 African markets— 5 active

Markets with LYNESTRENOL

🇬🇭Ghana
2 registrations
2 active
🇿🇼Zimbabwe
2 registrations
2 active
🇨🇮Côte d'Ivoire
1 registration
0 active
🇲🇼Malawi
1 registration
0 active
🇳🇬Nigeria
1 registration
0 active
🇸🇳Senegal
1 registration
1 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
FOREVER LYCIUM PLUS
TABLET, COATED; ORAL
🇿🇼ZimbabweFOREVER LIVING PRODUCTSactiveDec 2027
EXLUTON
TABLET; ORAL
🇿🇼ZimbabweORGANON SOUTH AFRICA (PTY) LTD.activeDec 2027
EXLUTION TABLETS🇬🇭Ghana—activeJun 2027
EXLUTION TABLETS🇬🇭Ghana—activeJun 2027
EXLUTON BFL 0,5MG COMPRIME BOITE DE 28🇨🇮Côte d'IvoireLABORATOIRE ORGANONexpiredDec 2023
EXLUTON 0.5MG TABLET
TABLET
🇲🇼Malawi—expiredMar 2023
EXLUTON TABLET
TABLET 1X 28'S
🇳🇬NigeriaMSD IDEA PHARMACEUTICALS NIG. LTD. MSD IDEA PHARMACEUTICALS NIG. LTD.expiredApr 2021
EXLUTION
comprimé / 500 mcg
🇸🇳SenegalMERCK SHARP ET DOHME-CHIBRETactive—

LYNESTRENOL in Africa — Regulatory Overview

LYNESTRENOL is registered across 6 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Zimbabwe, Côte d'Ivoire, Malawi and 2 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 8 registrations, 5 (63%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.